Physician profile
Nick Hoss
NPI 1700876604
$1,754.24
in general payments reported to CMS, 2019-2025
20 companies · $803 in 2025
The $803 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2022: $31.93 · 2024: $796 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $407.39 | 2024-2025 | Entyvio |
| Qol Medical, LLC | $196.06 | 2024-2025 | Sucraid, Sucraid |
| Ardelyx, INC. | $175.94 | 2024-2025 | Ibsrela |
| Janssen Biotech, INC. | $135.14 | 2024-2025 | Tremfya |
| Osiris Therapeutics INC. | $122.97 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.46 | 2024-2025 | Xifaxan, Relistor, Trulance |
| Phathom Pharmaceuticals, INC. | $85.03 | 2024-2025 | Voquezna |
| Aimmune Therapeutics, INC. | $69.27 | 2024-2025 | Zenpep |
| Regeneron Healthcare Solutions, INC. | $68.70 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $67.43 | 2024 | Dificid |
| Ipsen Biopharmaceuticals, INC | $61.48 | 2025 | Iqirvo |
| Evoke Pharma, INC. | $44.93 | 2024-2025 | |
| Celltrion USA INC. | $36.00 | 2024 | Vegzelma |
| Acacia Pharma INC | $31.93 | 2022 | |
| Mauna Kea Technologies, INC. | $28.69 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $26.69 | 2024 | |
| Intercept Pharmaceuticals, INC. | $22.72 | 2025 | |
| Biocon Biologics INC | $21.24 | 2024 | Hulio |
| Lilly USA, LLC | $17.92 | 2025 | Omvoh |
| Medtronic, INC. | $14.25 | 2024 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nick Hoss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.